Role of adult stem/progenitor cells in osseointegration and implant loosening

International Journal of Oral and Maxillofacial Implants

Volumn 26, Issue , 2011, Pages 50-62

  Tuan, Rocky S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CYTOKINE;

ADULT STEM CELL; APOPTOSIS; BONE; BONE DEVELOPMENT; BONE REGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DENTAL SURGERY; ENDOCYTOSIS; HUMAN; MESENCHYMAL STEM CELL; PHYSIOLOGY; REVIEW; SURFACE PROPERTY; TOOTH IMPLANTATION;

ADULT STEM CELLS; APOPTOSIS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINES; DENTAL IMPLANTS; DENTAL RESTORATION FAILURE; ENDOCYTOSIS; HUMANS; MESENCHYMAL STEM CELLS; OSSEOINTEGRATION; OSTEOGENESIS; SURFACE PROPERTIES;

EID: 79957835208     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Bostrom M, O’Keefe R. What experimental approaches (eg, in vivo, in vitro, tissue retrieval) are effective in investigating the biologic effects of particles? J Am Acad Orthop Surg 2008;16(suppl 1): S63-S67.
2. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968; 6: 230-247.
3. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9: 641-650.
4. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284: 143-147.
5. Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 2008;10: 223.
6. Nöth U, Steinert AF, Tuan RS. Technology insight: Adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol 2008;4: 371-380.
7. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970;3: 393-403.
8. Kuhn NZ, Tuan RS. Regulation of stemness and stem cell niche of mesenchymal stem cells: Implications in tumorigenesis and metastasis. J Cell Physiol 2010;222: 268-277.
9. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: Regulation of niche, selfrenewal and differentiation. Arthritis Res Ther 2007;9: 204.
10. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8: 315-317.
11. Nöth U, Osyczka AM, Tuli R, Hickok NJ, Danielson KG, Tuan RS. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 2002;20: 1060-1069.
12. De Bari C, Dell’Accio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001;44: 1928-1942.
13. Djouad F, Bony C, Haupl T, et al. Transcriptional profiles discriminate bone marrow derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 2007;9: R1304-R1315.
14. Hiraoka K, Grogan S, Olee T, Lotz M. Mesenchymal progenitor cells in adult human articular cartilage. Biorheology 2006;43: 447-454.
15. Sekiya I, Larson BL, Vuoristo JT, Cui JG, Prockop DJ. Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs). J Bone Miner Res 2004;19: 256-264.
16. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001;7: 211-228.
17. Nesti LJ, Jackson WM, Shanti RM, et al. Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. J Bone Joint Surg Am 2008;90: 2390-2398.
18. Janjanin S, Djouad F, Shanti RM, et al. Human palatine tonsil: A new potential tissue source of multipotent mesenchymal progenitor cells. Arthritis Res Ther 2008;10: R83.
19. Rzhaninova AA, Gornostaeva SN, Goldshtein DV. Isolation and phenotypical characterization of mesenchymal stem cells from human fetal thymus. Bull Exp Biol Med 2005;139: 134-140.
20. Shih DT, Lee DC, Chen SC, et al. Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells 2005;23: 1012-1020.
21. Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990;61: 1329-1337.
22. Sonoyama W, Liu Y, Yamaza T, et al. Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: A pilot study. J Endod 2008;34: 166-171.
23. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells 2005;23: 220-229.
24. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004;103: 1669-1675.
25. Yen BL, Huang HI, Chien CC, et al. Isolation of multipotent cells from human term placenta. Stem Cells 2005;23: 3-9.
26. Tuli R, Tuli S, Nandi S, et al. Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells 2003;21: 681-693.
27. Song L, Young NJ, Webb NE, Tuan RS. Origin and characterization of multipotential mesenchymal stem cells derived from adult human trabecular bone. Stem Cells Dev 2005;14: 712-721.
28. Tuli R, Nandi S, Li WJ, et al. Human mesenchymal progenitor cell-based tissue engineering of a single-unit osteochondral construct. Tissue Eng 2004;10: 1169-1179.
29. Bruder SP, Jaiswal N, Ricalton NS, Mosca JD, Kraus KH, Kadiyala S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res 1998;355(suppl): S247-S256.
30. Lozito T, Kolf C, Tuan RS. Microenvironmental regulation of adult mesenchymal stem cells. In: Rajasekhar VK, Vemuri M (eds). Regulatory Networks in Stem Cells. New York: Humana Press, 2009: 185-210.
31. Brånemark PI, Hansson BO, Adell et al. Osseointegrated implants in the treatment of the edentulous jaw. Scand J Plast Reconstr Surg 1997;16: 1-132.
32. Sinha RK, Tuan RS. In vitro analysis of the bone-implant interface. Semin Arthroplasty 1996;7: 47-57.
33. Sinha RK, Morris F, Shah SA, Tuan RS. Surface composition of orthopaedic implant metals regulates cell attachment spreading, and cytoskeletal organization of primary human osteoblasts in vitro. Clin Ortho 1994;305: 258-272.
34. Shah AK, Sinha RK, Hickok NJ, Tuan RS. High resolution morphometric analysis of human osteoblast adhesion on clinically relevant orthopaedic alloys. Bone 1999;24: 499-506.
35. Shah AK, Lazatin J, Sinha RK, Lennox T, Hickok NJ, Tuan RS. Mechanism of BMP-2 stimulated osteoblast adhesion to orthopaedic biomaterials. Biol Cell 1999;91: 131-142.
36. Groessner-Schreiber B, Tuan RS. Enhanced extracellular matrix production and mineralization by calvarial osteoblasts cultured on titanium surfaces in vitro. J Cell Sci 1992;101: 209-217.
37. Frisch SM, Vuori K, Ruoslahti E, Chan-Hui P-Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 1996;134: 793-799.
38. Hynes RO. Integrins: Bidirectional, allosteric signaling machines. Cell 2002;110: 673-687.
39. Schaller MD, Parsons JT. Focal adhesion kinase and associated proteins. Curr Opin Cell Biol 1994;6: 705-710.
40. Myllymaa S, Kaivosoja E, Myllymaa K, et al. Adhesion, spreading and osteogenic differentiation of mesenchymal stem cells cultured on micropatterned amorphous diamond, titanium, tantalum and chromium coatings on silicon. J Mater Sci Mater Med 2010;21: 329-341.
41. Olivares-Navarrete R, Hyzy S, Wieland M, Boyan BD, Schwartz Z. The roles of Wnt signaling modulators Dickkopf-1 (Dkk1) and Dickkopf-2 (Dkk2) and cell maturation state in osteogenesis on microstructured titanium surfaces. Biomaterials 2010;31: 2015-2024.
42. Dohan Ehrenfest DM, Coelho PG, Kang BS, Sul YT, Albrektsson T. Classification of osseointegrated implant surfaces: Materials, chemistry and topography. Trends Biotechnol 2010;28: 198-206.
43. Hickok NJ, Nöth U, Seghatoleslami R, et al. Integrin function and activation of signaling pathways in osteoblastic cells. Osteologie 2002;11: 75-85.
44. Nöth U, Tuli R, Seghatoleslami R, et al. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bonederived osteoblasts. Exp Cell Res 2003;291: 201-211.
45. Bobyn JD, Engh CA. Human histology of the bone-porous metal implant interface. Orthopaedics 1984;7: 1410-1422.
46. Goldring SR, Jasty M, Roelke MS, Rourke CM, Bringhurst FR, Harris WH. Formation of a synovial like membrane at the bone-cement interface. Its role in bone resorption and implant loosening after total hip replacement. Arthritis Rheum 1986;29: 836-842.
47. Harris WH, Schiller AL, Scholler JM, Freiberg RA, Scott R. Extensive localized bone resorption in the femur following total hip replacement. J Bone Joint Surg Am 1976;58: 612-618.
48. Maloney WJ, Smith RL, Schmalzried TP, Chiba J, Huene D, Rubash H. Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement. J Bone Joint Surg Am 1995;77: 1301-1310.
49. Konttinen YT, Zhao D, Beklen A, et al. The microenvironment around total hip replacement prostheses. Clin Orthop Relat Res 2005;430: 28-38.
50. Newby AC. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol 2008;28: 2108-2114.
51. Tuan RS, Lee FY, T Konttinen Y, Wilkinson JM, Smith RL. What are the local and systemic biologic reactions and mediators to wear debris, and what host factors determine or modulate the biologic response to wear particles? J Am Acad Orthop Surg 2008;16: S42-S48.
52. Lassus J, Salo J, Jiranek WA, et al. Macrophage activation results in bone resorption. Clin Orthop Relat Res 1998;352: 7-15.
53. Leibbrandt A, Penninger JM. RANKL/RANK as key factors for osteoclast development and bone loss in arthropathies. Adv Exp Med Biol 2009;649: 100-113.
54. Ramage SC, Urban NH, Jiranek WA, Maiti A, Beckman MJ. Expression of RANKL in osteolytic membranes: Association with fibroblastic cell markers. J Bone Joint Surg Am 2007; 89: 841-848.
55. Koreny T, Tunyogi-Csapo M, Gal I, Vermes C, Jacobs JJ, Glant TT. The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum 2006: 54: 3221-3232.
56. Seo S, Lee D, Cho S, et al. ERK signaling regulates macrophage colony-stimulating factor expression induced by titanium particles in MC3T3.E1 murine calvarial preosteoblastic cells. Ann N Y Acad Sci 2007;1117: 151-158.
57. Shanbhag AS, Kaufman AM, Hayata K, Rubash HE. Assessing osteolysis with use of high-throughput protein chips. J Bone Joint Surg Am 2007;89: 1081-1089.
58. Santerre JP, Labow RS, Boynton EL. The role of the macrophage in periprosthetic bone loss. Can J Surg 2000;43: 173-179.
59. Haynes DR. Bone lysis and inflammation. Inflamm Res 2004; 53: 596-600.
60. Yao J, Cs-Szabo G, Jacobs JJ, Kuettner KE, Glant TT. Suppression of osteoblast function by titanium particles. J Bone Joint Surg Am 1997;79: 107-112.
61. Pioletti DP, Takei H, Kwon SY, Wood D, Sung KL. The cytotoxic effect of titanium particles phagocytosed by osteoblasts. J Biomed Mater Res 1999;46: 399-407.
62. Kwon SY, Lin T, Takei H, et al. Alterations in the adhesion behavior of osteoblasts by titanium particle loading: Inhibition of cell function and gene expression. Biorheology 2001;38: 161-183.
63. Fritz EA, Glant TT, Vermes C, Jacobs JJ, Roebuck KA. Chemokine gene activation in human bone marrow-derived osteoblasts following exposure to particulate wear debris. J Biomed Mater Res A 2006;77: 192-201.
64. Wang ML, Tuli R, Manner PA, Sharkey PF, Hall DJ, Tuan RS. Direct and indirect induction of apoptosis in human mesenchymal stem cells in response to titanium particles. J Orthop Res 2003;21: 697-707.
65. Wang ML, Nesti LJ, Tuli R, et al. Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells. J Orthop Res 2002;20: 1175-1184.
66. Wang ML, Sharkey PF, Tuan RS. Particle bioreactivity and wear-mediated osteolysis. J Arthroplasty 2004;19: 1028-1038.
67. Okafor CC, Haleem-Smith H, Laqueriere P, Manner PA, Tuan RS. Particulate endocytosis mediates biological responses of human mesenchymal stem cells to titanium wear debris. J Orthop Res 2006;24: 461-473.
68. Chiu R, Ma T, Smith RL, Goodman SB. Kinetics of polymethylmethacrylate particle-induced inhibition of osteoprogenitor differentiation and proliferation. J Orthop Res 2007;25: 450-457.
69. Chiu R, Ma T, Smith RL, Goodman SB. Polymethylmethacrylate particles inhibit osteoblastic differentiation of bone marrow osteoprogenitor cells. J Biomed Mater Res A 2006;77: 850-856.
70. Wilkinson JM, Wilson AG, Stockley I, et al. Variation in the TNF gene promoter and risk of osteolysis after total hip arthroplasty. J Bone Miner Res 2003;18: 1995-2001.
71. Gordon A, Southam L, Loughlin J, et al. Variation in the secreted frizzled-related protein-3 gene and risk of osteolysis and heterotopic ossification after total hip arthroplasty. J Orthop Res 2007;25: 1665-1670.
72. Avila G, Misch K, Galindo-Moreno P, Wang HL. Implant surface treatment using biomimetic agents. Implant Dent 2009;18: 17-26.
73. Ho JE, Chung EH, Wall S, Schaffer DV, Healy KE. Immobilized sonic hedgehog N-terminal signaling domain enhances differentiation of bone marrow-derived mesenchymal stem cells. J Biomed Mater Res A 2007;15;83: 1200-1208.